Erythema Multiforme: A Case Report
Erythema multiforme (EM) is an acute inflammatory disease as a result of the allergic immune response mechanism when the patient exposes the stimulating factor, as the infection, the medication and the chemical uses. The lesions can occur in the skin and or the mucous membrane. The diversity of the clinical features depend on the organ involvement, to be the mucous membrane and the skin. In the oral cavity, EM commonly demonstrates as the bilaterally symmetry of the desquamated lesions. The present report was described a case of EM in 55-year-old female, with the oral mucous membrane desquamation, the painful sensation, and the subjective complaint was difficult to eat. The diagnosis of EM was established by the basis of the patient history and the clinical features. The histopathologic finding and the immunofluorescence finding were considered for the diagnostic confirmation. The patient was successfully treated by the systemic and the topical steroids. There were not found the any lesions when the patient avoided the stimulating factor, as the consumption of the pesticides contaminated in fried insects.
1. Shreyas N Shah, Girish R Chauhan, B.S Manjunatha, Kapil Dagrus. Drug induced Erythema Multiforme: two case series with review of literature. J Clin Diagn Res 2014; 8(9): ZH01–ZH04.
2. Inamadar AC, Palit A. Cutaneous reactions simulating Erythema Multiforme and Stevens Johnson syndrome due to occupational exposure to a plant-growth regulator. Indian J Dermatol Venereol Leprol 2007; 73(5): 330-332.
3. Martin S. Greenburge, Michael Glick, Jonathan A Ship. Burket’s Oral Medicine. 11th ed. Hamilton: BC Decker Inc; 2008: 53-55.
4. Scully C, Bagan J. Oral mucosal diseases: Erythema Multiforme. Br J Oral Maxillofac Surg 2008; 46: 90-95.
5. Williams PM, Conklin RJ. Erythema Multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin N Am 2005; 49: 67-76.
6. Martinez AB, Garcia VG, Meurman, Caballero LR. Immune-mediated diseases: What can be found in the oral cavity? Int J Dermatol2015; 54: 258-270.
7. Samim F, Auluck A, Zed C, William PM. Erythema Multiforme: A Review of Epidemiology, Pathogenesis, Clinical Features, and Treatment. Dent Clin N Am 2013; 57: 583-596.
8. Al-Johani KA, Fedele S, Porter SR. Erythema Multiforme and related disorder. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 13: 642-651.
9. Neville BW, Dam DD, Allen CM, Bouquot JE. Oral & Maxillofacial Pathology. 2nd ed. New Delhi: Elsevier; 2005: 674-677.
10. Rungsiyanon S, Kampalanon. Erythema multiforme. In : Thongprasom K: Advanced oral medicine. 2nd. Bangkok: Chulalongkorn University; 2010: 165-186 (in Thai)
11. Andreu Massot and Ana Gimenez-Arnau. Cutaneous adverse drug reaction type Erythema Multiforme major induced by eslicarbazepine. J Pharmacol Pharmacother 2014; 5(4): 271–227.
12. Pongsiriwet S, Sookkasem M. Oral Benign Mucous Membrane Pemphigoid: A case report. CM Dent J 2003; 24: 113-120. (in Thai)
13. Rakhi Issarani, Namdeo Prabhu. Etiopathogenesis of Erythema Multiforme – A Concise Review. Adv Dent & Oral Health 2017; 5(4): 1-5.
14. Spiewak R. Pesticides as a cause of occupational skin disease in farmer. Ann Agric Environ Med 2001; 8(1): 1-5.
15. Ahdout J, Haiey JC, Melvin W. Erythema Multiforme during anti-tumor necrosis factor treatmemt for plaque psoriasis. J Am Acad Dermatol 2010; 62: 874-879.
16. Edwards D, Boritz E, Cowen EW, Brown RS. Erythema Multiforme Major Following Treatment with Infliximab. Oral Surg Oral Med Oral Patho Oral Radiol 2013; 115(2): e36-e40.
17. Isaäc van der Waal . Atlas of Oral Diseases: A Guide for Daily Practice. 1st ed. Heidelberg: Springer; 2019: 95.
18. Arisawa EAL, Almeida JD, Carvalho YR, Cabral LAG. Clinicopathological analysis of oral mucous autoimmune disease: A 27-year study. Med Oral Patol Oral Cir Bucal 2008; 13(2): E94- E97.
19. Schifter M, Yeoh SC, Coleman H, Georgiou A. Oral mucosal diseases: the inflammatory dermatoses. Aus dent J 2010; 55(1): 23-38.
20. Thongprasom K, Dhanuthai K. Steroids in the treatment of lichen planus: a review. J Oral Science 2008; 50(4): 377-385.
21. Thongprasom K, Luengvisut P, Wongwatanakij A, Boonjatturus C. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral pathol Med 2003; 32: 315-322.
22. Patil A, Susmitha HR, Basappa S, Mahesh MS. Drug-induced Oral Candidiasis: A case Report. IJSS Case Reports & Reviews 2016; 2(12): 1-4.